Preclinical
N/A
Sponsors / Collaborators
Expesicor Inc
Preclinical
N/A
Sponsors / Collaborators
Stoke Therapeutics
Preclinical
N/A
Sponsors / Collaborators
Stoke Therapeutics
Phase 1
N/A
Sponsors / Collaborators
SK Life Science, Inc
Preclinical
N/A
Sponsors / Collaborators
Baylor College of Medicine, Epilepsy Research Foundation, NIH-NINDS (NS039941)
Preclinical
N/A
Sponsors / Collaborators
Baylor College of Medicine, NIH-NINDS (NS39941), Epilepsy Foundation (EF)
Preclinical
N/A
Sponsors / Collaborators
Neuroene Therapeutics
Phase 1
N/A
Sponsors / Collaborators
Adamas Pharmaceuticals, Epilepsy Foundation (EF)
New Formulations and Indications
Convection Enhanced Delivery of Anticonvulsant Toxins for the Treatment of Intractable Partial Epilepsy
Preclinical
N/A
Sponsors / Collaborators
University of California Davis; Medgenesis Therapeutix, Epilepsy Foundation (EF)
Disclaimer
The Epilepsy Foundation makes no claims of accuracy of the following data. Although every effort is made to continuously update this list, some errors are inevitable. Companies or academicians or others who are directly involved with any of the therapies listed here are strongly encouraged to keep us updated by contacting contactus@efa.org of any needed changes.